Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Fibric Acids"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 144
Tytuł:
Physician variation in the de-adoption of ineffective statin and fibrate therapy.
Autorzy:
Everhart A; University of Minnesota, Minneapolis, Minnesota, USA.; OptumLabs Visiting Fellow, Eden Prairie, Minnesota, USA.
Desai NR; Yale School of Medicine, Charlottesville, Virginia, USA.
Dowd B; University of Minnesota, Minneapolis, Minnesota, USA.
Herrin J; Yale School of Medicine, Charlottesville, Virginia, USA.
Higuera L; University of Minnesota, Minneapolis, Minnesota, USA.; Medtronic Plc, Mounds View, Minnesota, USA.
Jeffery MM; Mayo Clinic, Rochester, Minnesota, USA.
Jena AB; Harvard Medical School, Boston, Massachusetts, USA.; Massachusetts General Hospital, Boston, Massachusetts, USA.; National Bureau of Economic Research, Cambridge, Massachusetts, USA.
Ross JS; Yale School of Medicine, Charlottesville, Virginia, USA.
Shah ND; Mayo Clinic, Rochester, Minnesota, USA.
Smith LB; Urban Institute, Washington, District of Columbia, USA.
Karaca-Mandic P; University of Minnesota, Minneapolis, Minnesota, USA.; National Bureau of Economic Research, Cambridge, Massachusetts, USA.
Pokaż więcej
Źródło:
Health services research [Health Serv Res] 2021 Oct; Vol. 56 (5), pp. 919-931. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Diabetes Mellitus, Type 2/*drug therapy
Fibric Acids/*administration & dosage
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*administration & dosage
Hypolipidemic Agents/*administration & dosage
Practice Patterns, Physicians'/*statistics & numerical data
Aged ; Drug Therapy, Combination ; Drug Utilization ; Female ; Fibric Acids/therapeutic use ; Guideline Adherence ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Hypoglycemic Agents/therapeutic use ; Hypolipidemic Agents/therapeutic use ; Longitudinal Studies ; Male ; Medicare Part C/statistics & numerical data ; Middle Aged ; Practice Guidelines as Topic ; Risk Factors ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies.
Autorzy:
Dubińska-Magiera M; Department of Animal Developmental Biology, Faculty of Biological Sciences, University of Wrocław, Sienkiewicza 21, 50-335 Wrocław, Poland.
Migocka-Patrzałek M; Department of Animal Developmental Biology, Faculty of Biological Sciences, University of Wrocław, Sienkiewicza 21, 50-335 Wrocław, Poland.
Lewandowski D; Department of Animal Developmental Biology, Faculty of Biological Sciences, University of Wrocław, Sienkiewicza 21, 50-335 Wrocław, Poland.
Daczewska M; Department of Animal Developmental Biology, Faculty of Biological Sciences, University of Wrocław, Sienkiewicza 21, 50-335 Wrocław, Poland.
Jagla K; Genetics Reproduction and Development Institute (iGReD), INSERM 1103, CNRS 6293, University of Clermont Auvergne, 28 Place Henri Dunant, 63001 Clermont-Ferrand, France.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 May 26; Vol. 22 (11). Date of Electronic Publication: 2021 May 26.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Muscular Diseases*/chemically induced
Muscular Diseases*/metabolism
Muscular Diseases*/pathology
Fibric Acids/*adverse effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*adverse effects
Zebrafish/*metabolism
Animals ; Disease Models, Animal ; Fibric Acids/pharmacology ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Confirmation of Statin and Fibrate Use from Small-Volume Archived Plasma Samples by High-Throughput LC-MS/MS Method.
Autorzy:
Kusovschi JD; Clinical Chemistry Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
Ivanova AA; Clinical Chemistry Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
Gardner MS; Clinical Chemistry Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
McGarrah RW 3rd; Duke Molecular Physiology Institute, Duke University School of Medicine, Duke University, Durham, NC 27701, USA.
Kraus WE; Duke Molecular Physiology Institute, Duke University School of Medicine, Duke University, Durham, NC 27701, USA.
Kuklenyik Z; Clinical Chemistry Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
Pirkle JL; Clinical Chemistry Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
Barr JR; Clinical Chemistry Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Apr 27; Vol. 24 (9). Date of Electronic Publication: 2023 Apr 27.
Typ publikacji:
Journal Article
MeSH Terms:
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Humans ; Fibric Acids/therapeutic use ; Chromatography, Liquid ; Tandem Mass Spectrometry ; Atorvastatin/therapeutic use ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Fibrates Affect Levels of Phosphorylated p38 in Intestinal Cells in a Differentiation-Dependent Manner.
Autorzy:
Cizkova K; Department of Histology and Embryology, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.
Tauber Z; Department of Histology and Embryology, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Apr 22; Vol. 24 (9). Date of Electronic Publication: 2023 Apr 22.
Typ publikacji:
Journal Article
MeSH Terms:
PPAR alpha*/metabolism
Hypolipidemic Agents*/pharmacology
Humans ; Fibric Acids/pharmacology ; Caco-2 Cells ; Cell Differentiation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancer.
Autorzy:
Stokes WA; Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA.; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Behera M; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Jiang R; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Gutman DA; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.; Atlanta Veterans Affairs Health Care System, Decatur, Georgia, USA.
Huang Z; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Burns A; Atlanta Veterans Affairs Health Care System, Decatur, Georgia, USA.
Sebastian NT; Department of Radiation Oncology, Emory University, Atlanta, Georgia, USA.; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Sukhatme V; Morningside Center for Innovative and Affordable Medicine, Emory University, Atlanta, Georgia, USA.; GlobalCures, Inc, Newton, Massachusetts, USA.
Lowe MC; Morningside Center for Innovative and Affordable Medicine, Emory University, Atlanta, Georgia, USA.; Division of Surgical Oncology, Emory University, Atlanta, Georgia, USA.
Ramalingam SS; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA.
Sukhatme VP; Morningside Center for Innovative and Affordable Medicine, Emory University, Atlanta, Georgia, USA.
Moghanaki D; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, California, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (1), pp. 358-367. Date of Electronic Publication: 2022 May 24.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Humans ; Male ; Cohort Studies ; Immunotherapy ; Fibric Acids/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction.
Autorzy:
Kim NH; Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Kim SG; Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. .
Pokaż więcej
Źródło:
Diabetes & metabolism journal [Diabetes Metab J] 2020 Apr; Vol. 44 (2), pp. 213-221.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cardiovascular Diseases/*drug therapy
Cardiovascular System/*drug effects
Fibric Acids/*pharmacology
PPAR alpha/*agonists
Adult ; Atherosclerosis/drug therapy ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/prevention & control ; Clinical Trials as Topic ; Dyslipidemias/drug therapy ; Dyslipidemias/epidemiology ; Fibric Acids/therapeutic use ; Heart Disease Risk Factors ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Lipoproteins, HDL/drug effects ; Meta-Analysis as Topic ; Metabolic Syndrome/drug therapy ; Prevalence ; Republic of Korea/epidemiology ; Triglycerides/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Reporting quality and adherence of randomized controlled trials about statins and/or fibrates for diabetic retinopathy to the CONSORT checklist.
Autorzy:
Mozetic V; Ophthalmologist of Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil.
Leonel L; Discipline of Evidence-Based Medicine, Universidade Federal de São Paulo (Unifesp), São Paulo, Brasil.
Leite Pacheco R; Discipline of Evidence-Based Medicine, Universidade Federal de São Paulo (Unifesp), São Paulo, Brasil. .; Centro Universitário São Camilo, São Paulo, Brazil. .
de Oliveira Cruz Latorraca C; Discipline of Evidence-Based Medicine, Universidade Federal de São Paulo (Unifesp), São Paulo, Brasil.
Guimarães T; Discipline of Evidence-Based Medicine, Universidade Federal de São Paulo (Unifesp), São Paulo, Brasil.
Logullo P; EQUATOR Network, NDORMS, Oxford University, Oxford, UK.
Riera R; Discipline of Evidence-Based Medicine, Universidade Federal de São Paulo (Unifesp), São Paulo, Brasil.; Centre of Health Technology Assessment, Hospital Sírio-Libanês, São Paulo, Brazil.
Pokaż więcej
Źródło:
Trials [Trials] 2019 Dec 16; Vol. 20 (1), pp. 729. Date of Electronic Publication: 2019 Dec 16.
Typ publikacji:
Journal Article
MeSH Terms:
Data Accuracy*
Checklist/*standards
Diabetic Retinopathy/*drug therapy
Fibric Acids/*therapeutic use
Guideline Adherence/*standards
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use
Randomized Controlled Trials as Topic/*standards
Research Design/*standards
Diabetic Retinopathy/diagnosis ; Fibric Acids/adverse effects ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Strategies for Therapeutic Amelioration of Aberrant Plasma Zn Handling in Thrombotic Disease: Targeting Fatty Acid/Serum Albumin-Mediated Effects.
Autorzy:
Regan-Smith S; School of Medicine, University of St Andrews, St Andrews KY16 9TF, UK.
Fritzen R; School of Medicine, University of St Andrews, St Andrews KY16 9TF, UK.
Hierons SJ; School of Medicine, University of St Andrews, St Andrews KY16 9TF, UK.
Ajjan RA; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds LS2 9JT, UK.
Blindauer CA; Department of Chemistry, University of Warwick, Coventry CV4 7AL, UK.
Stewart AJ; School of Medicine, University of St Andrews, St Andrews KY16 9TF, UK.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Sep 07; Vol. 23 (18). Date of Electronic Publication: 2022 Sep 07.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hemostatics*
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Thrombosis*
Fatty Acids ; Fatty Acids, Nonesterified ; Fibric Acids ; Fibrinogen ; Humans ; Kininogen, High-Molecular-Weight ; Lipase ; Plasma/metabolism ; Serum Albumin/metabolism ; Serum Albumin, Human ; Zinc/chemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risk of diabetes with fibrates and statins: a pharmacoepidemiological study in VigiBase .
Autorzy:
Montastruc F; Service de Pharmacologie Médicale et Clinique, Centre de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, INSERM U 1027, CIC 1436, Centre Hospitalier Universitaire - Faculté de Médecine, Université de Toulouse, 37 allées Jules Guesde, 31000, Toulouse, France.
Benevent J; Service de Pharmacologie Médicale et Clinique, Centre de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, INSERM U 1027, CIC 1436, Centre Hospitalier Universitaire - Faculté de Médecine, Université de Toulouse, 37 allées Jules Guesde, 31000, Toulouse, France.
Rousseau V; Service de Pharmacologie Médicale et Clinique, Centre de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, INSERM U 1027, CIC 1436, Centre Hospitalier Universitaire - Faculté de Médecine, Université de Toulouse, 37 allées Jules Guesde, 31000, Toulouse, France.
Durrieu G; Service de Pharmacologie Médicale et Clinique, Centre de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, INSERM U 1027, CIC 1436, Centre Hospitalier Universitaire - Faculté de Médecine, Université de Toulouse, 37 allées Jules Guesde, 31000, Toulouse, France.
Sommet A; Service de Pharmacologie Médicale et Clinique, Centre de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, INSERM U 1027, CIC 1436, Centre Hospitalier Universitaire - Faculté de Médecine, Université de Toulouse, 37 allées Jules Guesde, 31000, Toulouse, France.
Montastruc JL; Service de Pharmacologie Médicale et Clinique, Centre de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, INSERM U 1027, CIC 1436, Centre Hospitalier Universitaire - Faculté de Médecine, Université de Toulouse, 37 allées Jules Guesde, 31000, Toulouse, France.
Pokaż więcej
Źródło:
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2019 Feb; Vol. 33 (1), pp. 108-112. Date of Electronic Publication: 2018 Aug 30.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Diabetes Mellitus/*epidemiology
Fibric Acids/*adverse effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*adverse effects
Hyperglycemia/*epidemiology
Adolescent ; Adult ; Adverse Drug Reaction Reporting Systems/statistics & numerical data ; Aged ; Databases, Factual/statistics & numerical data ; Diabetes Mellitus/etiology ; Drug Interactions ; Female ; Fibric Acids/administration & dosage ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage ; Hyperglycemia/etiology ; Male ; Middle Aged ; Pharmacoepidemiology ; Risk Factors ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia).
Autorzy:
Waldmann E; Medical Department IV, LMU Klinikum Grosshadern, Munich, Germany.
Wu L; Medical Department IV, LMU Klinikum Grosshadern, Munich, Germany.
Busygina K; Medical Department IV, LMU Klinikum Grosshadern, Munich, Germany.
Altenhofer J; Medical Department IV, LMU Klinikum Grosshadern, Munich, Germany.
Henze K; Medical Department IV, LMU Klinikum Grosshadern, Munich, Germany.
Folwaczny A; Medical Department IV, LMU Klinikum Grosshadern, Munich, Germany.
Parhofer KG; Medical Department IV, LMU Klinikum Grosshadern, Munich, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Mar 23; Vol. 17 (3), pp. e0265838. Date of Electronic Publication: 2022 Mar 23 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Anticholesteremic Agents*/therapeutic use
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Hypercholesterolemia*/chemically induced
Hyperlipidemias*/chemically induced
Hyperlipidemias*/drug therapy
Hyperlipoproteinemia Type III*/chemically induced
Hyperlipoproteinemia Type III*/drug therapy
Antibodies, Monoclonal, Humanized ; Apolipoproteins B ; Cholesterol ; Female ; Fibric Acids ; Humans ; Lipoproteins ; Male ; Proprotein Convertase 9
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pharmacophore-guided repurposing of fibrates and retinoids as GPR40 allosteric ligands with activity on insulin release.
Autorzy:
Cione E; Department of Pharmacy, Health and Nutritional Sciences (Department of Excellence 2018-2022), University of Calabria, Rende, Italy.
Caroleo MC; Department of Pharmacy, Health and Nutritional Sciences (Department of Excellence 2018-2022), University of Calabria, Rende, Italy.
Kagechika H; Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Manetti F; Department of Biotechnology, Chemistry and Pharmacy (Department of Excellence 2018-2022), University of Siena, Siena, Italy.
Pokaż więcej
Źródło:
Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2021 Dec; Vol. 36 (1), pp. 377-383.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Repositioning*
Fibric Acids/*pharmacology
Insulin/*metabolism
Receptors, G-Protein-Coupled/*agonists
Retinoids/*pharmacology
Allosteric Regulation/drug effects ; Aniline Compounds/pharmacology ; Animals ; Bezafibrate/pharmacology ; Cells, Cultured ; Dose-Response Relationship, Drug ; Humans ; Ligands ; Molecular Docking Simulation ; Molecular Structure ; Propionates/pharmacology ; Rats ; Receptors, G-Protein-Coupled/metabolism ; Structure-Activity Relationship
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review
Autorzy:
Chaicharn Deerochanawong
Sin Gon Kim
Yu-Cheng Chang
Pokaż więcej
Temat:
asian people
diabetes mellitus
dyslipidemia
fenofibrate
fibric acids
hypertriglyceridemia
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Źródło:
Diabetes & Metabolism Journal, Vol 48, Iss 2, Pp 184-195 (2024)
Opis pliku:
electronic resource
Relacje:
http://e-dmj.org/upload/pdf/dmj-2023-0168.pdf; https://doaj.org/toc/2233-6079; https://doaj.org/toc/2233-6087
Dostęp URL:
https://doaj.org/article/71a78d56ef4a4f1daec7e774e160ab4b  Link otwiera się w nowym oknie
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Comparative efficacy and safety of statin and fibrate monotherapy: A systematic review and meta-analysis of head-to-head randomized controlled trials.
Autorzy:
Blais JE; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Tong GKY; Pfizer Upjohn Hong Kong Limited, Hong Kong SAR, China.
Pathadka S; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Mok M; Department of Cardiology, University Hospital Geelong and Deakin University, Geelong, Victoria, Australia.
Wong ICK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.; Research Department of Practice and Policy, UCL School of Pharmacy, London, United Kingdom.
Chan EW; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Feb 09; Vol. 16 (2), pp. e0246480. Date of Electronic Publication: 2021 Feb 09 (Print Publication: 2021).
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms:
Fibric Acids/*adverse effects
Fibric Acids/*therapeutic use
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*adverse effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use
Animals ; Humans ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials.
Autorzy:
Sahebkar A; Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. .; School of Medicine, University of Western Australia, Perth, Australia. .
Simental-Mendía LE; Biomedical Research Unit, Mexican Social Security Institute, Durango, Mexico.
Watts GF; School of Medicine, University of Western Australia, Perth, Australia.; Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Australia.
Serban MC; Department of Functional Sciences, Discipline of Pathophysiology, 'Victor Babes' University of Medicine and Pharmacy, Timisoara, Romania.
Banach M; Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Lodz, Poland.
Pokaż więcej
Corporate Authors:
Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group
Źródło:
BMC medicine [BMC Med] 2017 Feb 03; Vol. 15 (1), pp. 22. Date of Electronic Publication: 2017 Feb 03.
Typ publikacji:
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms:
Fibric Acids/*administration & dosage
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*administration & dosage
Lipoprotein(a)/*blood
Atherosclerosis/blood ; Female ; Fibric Acids/pharmacology ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Randomized Controlled Trials as Topic ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Safety of fibrates in cholestatic liver diseases.
Autorzy:
Carrion AF; Division of Gastroenterology and Hepatology, University of Miami, Miami, FL, USA.
Lindor KD; Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, USA.; Office of University Provost, Arizona State University, Phoenix, AZ, USA.
Levy C; Division of Gastroenterology and Hepatology, University of Miami, Miami, FL, USA.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2021 Jun; Vol. 41 (6), pp. 1335-1343. Date of Electronic Publication: 2021 Mar 18.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
Cholagogues and Choleretics*/adverse effects
Liver Cirrhosis, Biliary*/drug therapy
Bezafibrate/adverse effects ; Fibric Acids/adverse effects ; Humans ; Ursodeoxycholic Acid/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis.
Autorzy:
Soret PA; Paris, France.
Lam L; Paris, France.
Carrat F; Paris, France.
Smets L; Leuven, Belgium.
Berg T; Leipzig, Germany.
Carbone M; Monza, Italy.
Invernizzi P; Monza, Italy.
Leroy V; Grenoble, France.
Trivedi P; Birmingham, UK.
Cazzagon N; Padova, Italy.
Weiler-Normann C; Hamburg, Germany.
Alric L; Toulouse, France.
Rosa-Hezode I; Créteil, France.
Heurgué A; Reims, France.
Cervoni JP; Besançon, France.
Dumortier J; Lyon, France.
Potier P; Orléans, France.
Roux O; Clichy, France.
Silvain C; Poitiers, France.
Bureau C; Toulouse, France.
Anty R; Nice, France.
Larrey D; Montpellier, France.
Levy C; Miami, USA.
Pares A; Barcelona, Spain.
Schramm C; Hamburg, Germany.
Nevens F; Leuven, Belgium.
Chazouillères O; Paris, France.
Corpechot C; Paris, France.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 May; Vol. 53 (10), pp. 1138-1146. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Cirrhosis, Biliary*/drug therapy
Chenodeoxycholic Acid/analogs & derivatives ; Cholagogues and Choleretics/therapeutic use ; Fibric Acids/therapeutic use ; Humans ; Retrospective Studies ; Ursodeoxycholic Acid/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Combination of atorvastatin and gemfibrozil plus physical activity: an animal model of statin/fibrate-induced myopathy.
Autorzy:
Zabihi M; Pharmaceutical Sciences Research Center, School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Askarian F; School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Hekmatimoghaddam S; Department of Advanced Medical Sciences and Technologies, School of Paramedicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Zabihi MS; School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Vahidi F; School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Pokaż więcej
Źródło:
Somatosensory & motor research [Somatosens Mot Res] 2021 Mar; Vol. 38 (1), pp. 90-94. Date of Electronic Publication: 2020 Dec 02.
Typ publikacji:
Journal Article
MeSH Terms:
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/toxicity
Muscular Diseases*/chemically induced
Animals ; Atorvastatin/toxicity ; Disease Models, Animal ; Fibric Acids ; Gemfibrozil/toxicity ; Rats
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development and validation of liquid chromatography-tandem mass spectrometric method for the quantification of ciprofibrate from human plasma.
Autorzy:
Shah D; Indukaka Ipcowala College of Pharmacy, Beyond GIDC, P.Box No. 53, Vitthal Udyognagar, New Vallabh Vidyanagar, Dist-Anand, Gujarat 388121, India .
Mavani D; Indukaka Ipcowala College of Pharmacy, Beyond GIDC, P.Box No. 53, Vitthal Udyognagar, New Vallabh Vidyanagar, Dist-Anand, Gujarat 388121, India.
Patel H; Zydus Research Center, Cadila Healthcare Ltd, Moraiya, Dist-Ahmedabad, Gujarat 388210, India.
Baldania S; Indukaka Ipcowala College of Pharmacy, Beyond GIDC, P.Box No. 53, Vitthal Udyognagar, New Vallabh Vidyanagar, Dist-Anand, Gujarat 388121, India.
Bhatt K; Indukaka Ipcowala College of Pharmacy, Beyond GIDC, P.Box No. 53, Vitthal Udyognagar, New Vallabh Vidyanagar, Dist-Anand, Gujarat 388121, India.
Chhalotiya U; Indukaka Ipcowala College of Pharmacy, Beyond GIDC, P.Box No. 53, Vitthal Udyognagar, New Vallabh Vidyanagar, Dist-Anand, Gujarat 388121, India.
Pokaż więcej
Źródło:
Journal of chromatographic science [J Chromatogr Sci] 2015 Feb; Vol. 53 (2), pp. 219-25. Date of Electronic Publication: 2014 May 15.
Typ publikacji:
Journal Article
MeSH Terms:
Chromatography, Liquid/*methods
Fibric Acids/*blood
Tandem Mass Spectrometry/*methods
Drug Stability ; Fibric Acids/chemistry ; Fibric Acids/pharmacokinetics ; Humans ; Limit of Detection ; Linear Models ; Reproducibility of Results
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Fibrate Use and Patients with Chronic Kidney Disease.
Autorzy:
Smith CA; Nephrology Nurse Practitioner, Renal Consultants, PLLC, South Charleston, WV.; Leader of ANNA's Advanced Practice SPN.; member of ANNA's Commonwealth Chapter.
Pokaż więcej
Źródło:
Nephrology nursing journal : journal of the American Nephrology Nurses' Association [Nephrol Nurs J] 2020 Sep-Oct; Vol. 47 (5), pp. 475-477.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiovascular Diseases*
Renal Insufficiency, Chronic*/therapy
Fibric Acids ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Curbing Lipids: Impacts ON Cancer and Viral Infection.
Autorzy:
Dutta A; Department of Microbiology and Immunology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, 3333 Green Bay Road, North Chicago, IL 60064, USA. .
Sharma-Walia N; Department of Microbiology and Immunology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, 3333 Green Bay Road, North Chicago, IL 60064, USA. .
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2019 Feb 02; Vol. 20 (3). Date of Electronic Publication: 2019 Feb 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lipid Metabolism*
Neoplasms/*metabolism
Virus Diseases/*metabolism
Animals ; Arachidonic Acid/metabolism ; Biomarkers ; Cholesterol/biosynthesis ; Energy Metabolism ; Fatty Acid Synthases/metabolism ; Fibric Acids/adverse effects ; Fibric Acids/therapeutic use ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Metabolic Networks and Pathways ; Neoplasms/etiology ; PPAR alpha/agonists ; Signal Transduction ; Virus Diseases/complications ; Virus Diseases/virology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 144

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies